CD BioSciences, a US-based biotechnology company focusing on the development of imaging technologies, is excited to announce the launch of its new Immune System Tissue Microarrays for the scientific ...

With respect to assay development, quality assurance and, ultimately, clinical adoption, the primary subject of this review, these advantages are critical. Implicit with these advantages, TMAs enable ...

EYSINS, Switzerland, April 3, 2025 /PRNewswire/ --Today, AliveDx announces it has submitted 510(k) premarket notification to the U.S. Food and Drug Administration (FDA) for the MosaiQ AiPlex ® ...

Aperio Technologies, Inc. has launched TMALab II, the latest release of the company’s web-based digital pathology information management system, built specifically for researchers who use Tissue ...

Oridis Biomed has announced that it has entered into a license agreement with the National Institutes of Health (NIH) for the worldwide commercial use of NIH's proprietary Tissue microarray (TMA) ...

For connective tissue diseases, the multiplex assay is designed to rapidly detect and identify up to 1275 disease markers per hour. Seamless, microarray-internal calibration and quality control as ...